Home > Cardiology > ACC 2022 > Interventional and Structural Cardiology > COMPLETE revascularisation improves angina-related QoL

COMPLETE revascularisation improves angina-related QoL

Presented By
Prof. Shamir Mehta, McMaster University, Canada
Conference
ACC 2022
Trial
COMPLETE
Doi
https://doi.org/10.55788/f3ff3e03
A prespecified analysis of the COMPLETE trial showed that percutaneous coronary intervention (PCI) improved angina-related quality of life (QoL) in patients with ST-elevation myocardial infarction (STEMI) and coronary artery disease (CAD), with more improvement noted in patients receiving complete revascularisation over culprit lesion-only revascularisation. Patients with complete revascularisation were more likely to be angina-free at 3 years than those in the culprit-lesion group. The previously published COMPLETE trial showed that complete revascularisation (n=2,016) was superior to culprit-only revascularisation (n=2,025) at reducing death or myocardial infarction over 3 years of follow-up [1]. Prof. Shamir Mehta (McMaster University, Canada) presented a prespecified analysis that focused on health-related QoL outcomes measured with the 19-item Seattle Angina Questionnaire (SAQ) at baseline, 6 months, and 3 years [2]. The primary outcome results...


Please login to read the full text of the article.


If you have no account yet, please register now.





Posted on